Cannabis Investment Club

[DarthYoda]

Upcoming FDA+Cannabinoids meeting could shake things up for hemp and cannabis stocks...

"June 14, 2022 Meeting of the Science Board to the FDA"...

Agenda: The meeting presentations
will be heard, viewed, captioned, and
recorded through an online
teleconferencing platform. The Science
Board to the Food and Drug
Administration will consider challenges
in evaluating the safety of dietary
supplement and food ingredients with
predicted pharmacological activity,
utilizing cannabinoids as a case study.

https://www.federalregister.gov/documents/2022/05/18/2022-10697/science-board-to-the-food-and-drug-administration-advisory-committee-notice-of-meeting

https://www.fda.gov/advisory-committees/science-board-food-and-drug-administration/2022-meeting-materials-science-board-fda

Other ingredients used in supplements and food available in the US also could be on the agency's radar for generating pharmacological activity.

Those ingredients include:

kratom, a botanical marketed for its calming and anti-inflammatory benefits;

the amino acid N-acetyl-L-cysteine used to increase glutathione levels and support respiratory health and detoxification in the liver and kidney;

and numerous analogs of pharmaceutical stimulants used in non-compliant weight loss and sports training supplements.

Cannabinoids, though, are the focus of this Science Board discussion. And for good reason.

https://hbw.pharmaintelligence.informa.com/RS152545/Everywhere-In-Supplements-And-Food-Is-Hemp-Safe-Enough-To-Be-Lawful-US-FDA-Wants-Science-Boards-Help-Solving-Regulatory-Conundrum